Avandia should remain on the market, majority of FDA advisory panel says - Washington Post

New York Times (blog)

Avandia should remain on the market, majority of FDA advisory panel says Washington Post Federal advisers delivered a decidedly mixed verdict Wednesday on the diabetes drug Avandia, with a significant number of experts voting to recommend that it be be removed from the market because of safety concerns but a majority voting to ... FDA Panel Recommends Keeping Glaxo's Avandia On US Market W »